Free Trial

Charles River Laboratories International (CRL) SEC Filings & 10K Form

Charles River Laboratories International logo
$151.02 +0.02 (+0.02%)
Closing price 06/11/2025 03:59 PM Eastern
Extended Trading
$151.11 +0.09 (+0.06%)
As of 06:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Charles River Laboratories International SEC Filings

DateFilerForm TypeView
06/10/2025
3:22 PM
Charles River Laboratories International (Issuer)
Mintz Mark (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/09/2025
3:21 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:40 PM
Charles River Laboratories International (Issuer)
Graves Paul W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:42 PM
Charles River Laboratories International (Issuer)
Enyedy Mark J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:45 PM
Ceesay Abraham (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:38 PM
Barg Steven (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:46 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:49 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:52 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
4:18 PM
Charles River Laboratories International (Issuer)
Graves Paul W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2025
4:23 PM
Charles River Laboratories International (Issuer)
Enyedy Mark J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2025
4:26 PM
Barg Steven (Reporting)
Charles River Laboratories International (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2025
4:29 PM
Ceesay Abraham (Reporting)
Charles River Laboratories International (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2025
3:54 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
3:58 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:08 PM
Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
3:38 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
3:41 PM
Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
2:33 PM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2025
9:44 AM
Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
8:09 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:08 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
6:15 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
4:44 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SCHEDULE 13G/A
04/02/2025
7:00 AM
Charles River Laboratories International (Filer)
Form DEF 14A
04/02/2025
7:06 AM
Charles River Laboratories International (Filer)
Form ARS
02/26/2025
3:18 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:36 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:38 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:41 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:30 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
11:36 AM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
8:07 AM
Charles River Laboratories International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
6:19 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
4:17 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:22 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:25 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:27 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
7:04 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:42 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
11/08/2024
5:21 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
3:23 PM
Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:16 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:21 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
08/13/2024
3:17 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:13 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
12:34 PM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:15 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:21 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CRL) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners